At a glance

ClinicalIndex Comparison Record

N/ACompleted· 411 enrolled

Drug / intervention

Enoxaparin +1 moredrug

Likely dose

Enoxaparin 30mgfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00358735

NCT00358735N/ACompleted

Compare CT.gov

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty (THA): Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

Medical Compression Systems·interventional·Posted Aug 1, 2006·Updated Oct 30, 2014

In Brief

A clinical study evaluating ActiveCare CECT device and Enoxaparin for Deep Vein Thrombosis of Lower Limb and 2 related conditions. Completed, enrolled 411 participants across 9 sites.

Detailed Summary

Evaluation of the safety and effectiveness of ActiveCare+ CECT device +/- baby dose aspirin (81 mg QD) for lowering the potential risk for bleeding and of DVT during and after THA surgery in comparison with LMWH.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDeep Vein Thrombosis of Lower Limb, Pulmonary Embolism (PE), Bleeding

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartJun 2006

First PostedAug 2006

Primary CompletionSep 2008

Study CompletionDec 2008

TodayJul 2026

First PostedAug 1, 2006

Enrollment StartJun 1, 2006

Primary CompletionSep 1, 2008

Study CompletionDec 1, 2008

TodayJul 2, 2026

Enrollment to primary: 2.3 yearsPosted 19.9 years ago

Interventions

ActiveCare CECT devicedevice

Patients will be treated with the ActiveCare+ CECT device starting after the induction of anesthesia, throughout the surgery and for 10-12 days after surgery. Baby aspirin (81 mg) QD can be added (depending on surgeon preference) 12-24 hours after surgery. Post discharge prophylaxis is the same for the remainder of the 10-12 days. Patients will wear the device to the duplex ultrasound when it will be discontinued by nurse.

Enoxaparindrug

Patients will be treated with Enoxaparin (Lovenox) for a total of 10 days beginning with 30mg BID starting 12-24 hours after surgery and continued until hospital discharge. Post discharge prophylaxis will be Enoxaparin 40mg QD for the remainder of the 10 days.